Cosylab to provide the control software of Australia’s first proton therapy unit

Published on

Radiance 330 treatment room. (Image courtesy of Cosylab)

AVA partner Cosylab has spent the last four years actively developing, fine-tuning and integrating the Treatment Delivery Control System and the Motion Control System for the Radiance 330 Proton Therapy System in close collaboration with ProTom International.

The new Australian Bragg Centre in Adelaide, which is the first proton therapy unit in Australia, has now chosen ProTom’s Radiance 330 device as its functional core and, with it, Cosylab’s embedded systems-software.

The Australian Bragg Centre will treat an estimated 600 to 700 patients each year when it becomes fully operational at the end of 2024.

The Radiance 330 PT system utilizes an integrated imaging and control system, and advanced pencil-beam scanning technology. The latter is one of the most advanced forms of proton therapy treatment, as it enables the system to apply superior dose sculpting and higher beam efficiencies than other methods of proton therapy. Pencil-beam scanning technology also reduces the adverse side-effects to patients and improves their long-term outcome and quality of life.

Thus Cosylab has participated in the successful development of one of the smallest and lightest proton therapy systems on the market which is based on a very compact synchrotron particle accelerator.